✦ LIBER ✦

Management of Acute Steroid-Resistant Rejection after Liver Transplantation

✍ Scribed by Klaus-Peter Platz; Andrea R. Mueller; Michael Zytowski; Peter Lemmens; Hartmut Lobeck; Peter Neuhaus

Publisher: Springer
Year: 1996
Tongue: English
Weight: 168 KB
Volume: 20
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s002689900160

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steroid-resistant acute allograft reject

Steroid-resistant acute allograft rejection in renal transplantation

✍ Guido Filler; Shih-Han S. Huang; Ajay P. Sharma 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 80 KB

Antithymocyte treatment of steroid-resis

Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation

✍ Mohan Shenoy; Denise Roberts; Nicholas D. Plant; Malcolm A. Lewis; Nicholas J.A. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 92 KB

Incidence, risk factors, and outcome of

Incidence, risk factors, and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantation

✍ Clara G. E. Bijleveld; Ids J. Klompmaker; Arie P. Berg; Annet S. H. Gouw; Bouke 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 529 KB

Acute cellular rejection after liver tra

Acute cellular rejection after liver transplantation: Variability, morbidity, and mortality

✍ Fisher, Laurel R. ;Henley, Keith S. ;Lucey, Michael R. 📂 Article 📅 1995 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 486 KB

Acute cellular rejection of the allograft is a potentially serious complication after liver transplantation, yet its true incidence is unknown. We therefore investigated the frequency of acute cellular rejection reported by transplant centers and its impact on morbidity and mortality. Morbidity was

Primary liver disease as a determinant f

Primary liver disease as a determinant for acute rejection after liver transplantation

✍ C. A. Seiler; Jean-Francois Dufour; Eberhard L. Renner; Martin Schilling; Markus 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 43 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir